Parkinsonism and rapidly progressive dementia secondary to free-living ameba
Objective: Present an original case description of a patient with amebic meningoencephalitis. Background: Parkinsonism could be caused by degenerative disorders, brain injuries, drugs, toxins, and…Early diagnosis of progressive supranuclear palsy using quantitative MRI analysis of brain structure
Objective: We examined whetherquantitative MRI analysis of brain structure was useful for early diagnosis of PSP. Background: Quantitative analysis of brain structure by means of…Serological analysis of circulating Alpha Synuclein protein levels by Surface Plasmon Resonance (SPR) In Parkinson’s disease
Objective: α-synuclein (α-Syn) is a presynaptic protein whose overexpression or misfolding contributes to the pathophysiology of Parkinson’s disease (PD). This study aims to estimate the…Drooling in Parkinson’s Disease: A [123I]FP-CIT SPECT study
Objective: Evaluate the association between drooling and striatal dopamine terminals. Test the assumption that drooling correlates with disease progression in de novo Parkinson’s disease (PD)…PSP-like syndrome after aortic in adults (Mokri syndrome)
Objective: Characterize the syndrome resembling progressive supranuclear palsy (PSP) following aortic surgery. Background: Mokri, et al. reported a PSP-like syndrome seemingly triggered by aortic surgery…Hoover’s Sign in Parkinson’s Disease
Objective: To study applicability of Hoover's sign to diagnostics of functional component in PD. Background: It has been reported that Parkinson’s Disease (PD) patients have…Osteopathic Manipulative Medicine to Improve Balance and Quality of Life in Parkinson Disease
Objective: To examine the effects of Osteopathic Manipulative Medicine (OMM) using a pre-defined protocol for 6 weeks and compare that to a 6-week counseling protocol…Ambroxol treatment of primary macrophages derived from patients with GBA-associated Parkinson’s disease
Objective: The aim was to evaluate the effectiveness of the restoration of GCase activity in macrophages from GBA-PD patients using pharmacological chaperone ambroxol. Background: Mutations…MDS-UPDRS Part III predictors of Part II Item Scores in PPMI
Objective: To identify the items in Part III of the MDS-UPDRS scale that are predictive to Part II items in early PD patients. Background: It…A cortical signature of motor response to dopaminergic therapy in Parkinson’s disease
Objective: To investigate whether cortical oscillations involved in sensorimotor processes might predict motor symptom response to dopaminergic treatment (MSRD) in Parkinson’s disease (PD). Background: MSRD…
- « Previous Page
- 1
- …
- 60
- 61
- 62
- 63
- 64
- …
- 217
- Next Page »